Selumetinib MEK inhibitor



Trial Studied treatment Control Patients Size Study type Results NCT

Melanoma - MEK inhibitor in all type of patients

Kirkwood, 2012selumetinibtemozolomideNA
KirkwoodselumetinibtemozolomideNA